-
1
-
-
77954910364
-
Role of the polycomb group proteins in hematopoietic stem cells
-
Konuma T., Oguro H., Iwama A. Role of the polycomb group proteins in hematopoietic stem cells. Dev. Growth Differ. 2010, 52:505-516.
-
(2010)
Dev. Growth Differ.
, vol.52
, pp. 505-516
-
-
Konuma, T.1
Oguro, H.2
Iwama, A.3
-
2
-
-
0037111831
-
Histone methyltransferase activity associated with a human multiprotein complex containing the enhancer of zeste protein
-
Kuzmichev A., Nishioka K., Erdjument-Bromage H., Tempst P., Reinberg D. Histone methyltransferase activity associated with a human multiprotein complex containing the enhancer of zeste protein. Genes Dev. 2002, 16:2893-2905.
-
(2002)
Genes Dev.
, vol.16
, pp. 2893-2905
-
-
Kuzmichev, A.1
Nishioka, K.2
Erdjument-Bromage, H.3
Tempst, P.4
Reinberg, D.5
-
3
-
-
0036830642
-
Role of histone H3 lysine 27 methylation in polycomb-group silencing
-
Cao R., Wang L., Wang H., Xia L., Erdjument-Bromage H., Tempst P., Jones R.S., Zhang Y. Role of histone H3 lysine 27 methylation in polycomb-group silencing. Science 2002, 298:1039-1043.
-
(2002)
Science
, vol.298
, pp. 1039-1043
-
-
Cao, R.1
Wang, L.2
Wang, H.3
Xia, L.4
Erdjument-Bromage, H.5
Tempst, P.6
Jones, R.S.7
Zhang, Y.8
-
4
-
-
0141816752
-
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
-
Kleer C.G., Cao Q., Varambally S., Shen R., Ota I., Tomlins S.A., Ghosh D., Sewalt R.G., Otte A.P., Hayes D.F., Sabel M.S., Livant D., Weiss S.J., Rubin M.A., Chinnaiyan A.M. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:11606-11611.
-
(2003)
Proc. Natl. Acad. Sci. U. S. A.
, vol.100
, pp. 11606-11611
-
-
Kleer, C.G.1
Cao, Q.2
Varambally, S.3
Shen, R.4
Ota, I.5
Tomlins, S.A.6
Ghosh, D.7
Sewalt, R.G.8
Otte, A.P.9
Hayes, D.F.10
Sabel, M.S.11
Livant, D.12
Weiss, S.J.13
Rubin, M.A.14
Chinnaiyan, A.M.15
-
5
-
-
18644382388
-
The polycomb group protein EZH2 is involved in progression of prostate cancer
-
Varambally S., Dhanasekaran S.M., Zhou M., Barrette T.R., Kumar-Sinha C., Sanda M.G., Ghosh D., Pienta K.J., Sewalt R.G., Otte A.P., Rubin M.A., Chinnaiyan A.M. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002, 419:624-629.
-
(2002)
Nature
, vol.419
, pp. 624-629
-
-
Varambally, S.1
Dhanasekaran, S.M.2
Zhou, M.3
Barrette, T.R.4
Kumar-Sinha, C.5
Sanda, M.G.6
Ghosh, D.7
Pienta, K.J.8
Sewalt, R.G.9
Otte, A.P.10
Rubin, M.A.11
Chinnaiyan, A.M.12
-
6
-
-
36349017912
-
A polycomb repression signature in metastatic prostate cancer predicts cancer outcome
-
Yu J., Yu J., Rhodes D.R., Tomlins S.A., Cao X., Chen G., Mehra R., Wang X., Ghosh D., Shah R.B., Varambally S., Pienta K.J., Chinnaiyan A.M. A polycomb repression signature in metastatic prostate cancer predicts cancer outcome. Cancer Res. 2007, 67:10657-10663.
-
(2007)
Cancer Res.
, vol.67
, pp. 10657-10663
-
-
Yu, J.1
Yu, J.2
Rhodes, D.R.3
Tomlins, S.A.4
Cao, X.5
Chen, G.6
Mehra, R.7
Wang, X.8
Ghosh, D.9
Shah, R.B.10
Varambally, S.11
Pienta, K.J.12
Chinnaiyan, A.M.13
-
7
-
-
60149096212
-
Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1
-
Gonzalez M.E., Li X., Toy K., DuPrie M., Ventura A.C., Banerjee M., Ljungman M., Merajver S.D., Kleer C.G. Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1. Oncogene 2009, 28:843-853.
-
(2009)
Oncogene
, vol.28
, pp. 843-853
-
-
Gonzalez, M.E.1
Li, X.2
Toy, K.3
DuPrie, M.4
Ventura, A.C.5
Banerjee, M.6
Ljungman, M.7
Merajver, S.D.8
Kleer, C.G.9
-
8
-
-
77955541508
-
Regulation of tumor angiogenesis by EZH2
-
Lu C., Han H.D., Mangala L.S., Ali-Fehmi R., Newton C.S., Ozbun L., Armaiz-Pena G.N., Hu W., Stone R.L., Munkarah A., Ravoori M.K., Shahzad M.M., Lee J.W., Mora E., Langley R.R., Carroll A.R., Matsuo K., Spannuth W.A., Schmandt R., Jennings N.B., Goodman B.W., Jaffe R.B., Nick A.M., Kim H.S., Guven E.O., Chen Y.H., Li L.Y., Hsu M.C., Coleman R.L., Calin G.A., Denkbas E.B., Lim J.Y., Lee J.S., Kundra V., Birrer M.J., Hung M.C., Lopez-Berestein G., Sood A.K. Regulation of tumor angiogenesis by EZH2. Cancer Cell 2010, 18:185-197.
-
(2010)
Cancer Cell
, vol.18
, pp. 185-197
-
-
Lu, C.1
Han, H.D.2
Mangala, L.S.3
Ali-Fehmi, R.4
Newton, C.S.5
Ozbun, L.6
Armaiz-Pena, G.N.7
Hu, W.8
Stone, R.L.9
Munkarah, A.10
Ravoori, M.K.11
Shahzad, M.M.12
Lee, J.W.13
Mora, E.14
Langley, R.R.15
Carroll, A.R.16
Matsuo, K.17
Spannuth, W.A.18
Schmandt, R.19
Jennings, N.B.20
Goodman, B.W.21
Jaffe, R.B.22
Nick, A.M.23
Kim, H.S.24
Guven, E.O.25
Chen, Y.H.26
Li, L.Y.27
Hsu, M.C.28
Coleman, R.L.29
Calin, G.A.30
Denkbas, E.B.31
Lim, J.Y.32
Lee, J.S.33
Kundra, V.34
Birrer, M.J.35
Hung, M.C.36
Lopez-Berestein, G.37
Sood, A.K.38
more..
-
9
-
-
84863926596
-
Imatinib causes epigenetic alterations of PTEN gene via upregulation of DNA methyltransferases and polycomb group proteins
-
Nishioka C., Ikezoe T., Yang J., Udaka K., Yokoyama A. Imatinib causes epigenetic alterations of PTEN gene via upregulation of DNA methyltransferases and polycomb group proteins. Blood Cancer J. 2011, 1:e48.
-
(2011)
Blood Cancer J.
, vol.1
, pp. e48
-
-
Nishioka, C.1
Ikezoe, T.2
Yang, J.3
Udaka, K.4
Yokoyama, A.5
-
10
-
-
84872344025
-
EZH2 is regulated by ERK/AKT and targets integrin alpha2 gene to control epithelial-mesenchymal transition and anoikis in colon cancer cells
-
Ferraro A., Mourtzoukou D., Kosmidou V., Avlonitis S., Kontogeorgos G., Zografos G., Pintzas A. EZH2 is regulated by ERK/AKT and targets integrin alpha2 gene to control epithelial-mesenchymal transition and anoikis in colon cancer cells. Int. J. Biochem. Cell Biol. 2013, 45:243-254.
-
(2013)
Int. J. Biochem. Cell Biol.
, vol.45
, pp. 243-254
-
-
Ferraro, A.1
Mourtzoukou, D.2
Kosmidou, V.3
Avlonitis, S.4
Kontogeorgos, G.5
Zografos, G.6
Pintzas, A.7
-
11
-
-
57849109399
-
Imatinib resistance in CML
-
Volpe G., Panuzzo C., Ulisciani S., Cilloni D. Imatinib resistance in CML. Cancer Lett. 2009, 274:1-9.
-
(2009)
Cancer Lett.
, vol.274
, pp. 1-9
-
-
Volpe, G.1
Panuzzo, C.2
Ulisciani, S.3
Cilloni, D.4
-
12
-
-
84930030402
-
Update on emerging treatments for chronic myeloid leukemia
-
Fava C., Morotti A., Dogliotti I., Saglio G., Rege-Cambrin G. Update on emerging treatments for chronic myeloid leukemia. Expert Opin. Emerg. Drugs 2015, 20:183-196.
-
(2015)
Expert Opin. Emerg. Drugs
, vol.20
, pp. 183-196
-
-
Fava, C.1
Morotti, A.2
Dogliotti, I.3
Saglio, G.4
Rege-Cambrin, G.5
-
13
-
-
84925988995
-
Causes of resistance and treatment choices of second- and third-line treatment in chronic myelogenous leukemia patients
-
Hochhaus A., Ernst T., Eigendorff E., La Rosée P. Causes of resistance and treatment choices of second- and third-line treatment in chronic myelogenous leukemia patients. Ann. Hematol. 2015, 94:133-140.
-
(2015)
Ann. Hematol.
, vol.94
, pp. 133-140
-
-
Hochhaus, A.1
Ernst, T.2
Eigendorff, E.3
La Rosée, P.4
-
14
-
-
67649371461
-
DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
-
Miranda T.B., Cortez C.C., Yoo C.B., Liang G., Abe M., Kelly T.K., Marquez V.E., Jones P.A. DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Mol. Cancer Ther. 2009, 8:1579-1588.
-
(2009)
Mol. Cancer Ther.
, vol.8
, pp. 1579-1588
-
-
Miranda, T.B.1
Cortez, C.C.2
Yoo, C.B.3
Liang, G.4
Abe, M.5
Kelly, T.K.6
Marquez, V.E.7
Jones, P.A.8
-
15
-
-
34247625135
-
Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells
-
Tan J., Yang X., Zhuang L., Jiang X., Chen W., Lee P.L., Karuturi R.K., Tan P.B., Liu E.T., Yu Q. Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev. 2007, 21:1050-1063.
-
(2007)
Genes Dev.
, vol.21
, pp. 1050-1063
-
-
Tan, J.1
Yang, X.2
Zhuang, L.3
Jiang, X.4
Chen, W.5
Lee, P.L.6
Karuturi, R.K.7
Tan, P.B.8
Liu, E.T.9
Yu, Q.10
-
16
-
-
84927709697
-
Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells
-
Hibino S., Saito Y., Muramatsu T., Otani A., Kasai Y., Kimura M., Saito H. Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells. Oncogenesis 2014, 3:e104.
-
(2014)
Oncogenesis
, vol.3
, pp. e104
-
-
Hibino, S.1
Saito, Y.2
Muramatsu, T.3
Otani, A.4
Kasai, Y.5
Kimura, M.6
Saito, H.7
-
17
-
-
33751163757
-
MicroRNA expression and function in cancer
-
Garzon R., Fabbri M., Cimmino A., Calin G.A., Croce C. MicroRNA expression and function in cancer. Trends Mol. Med. 2006, 12:580-587.
-
(2006)
Trends Mol. Med.
, vol.12
, pp. 580-587
-
-
Garzon, R.1
Fabbri, M.2
Cimmino, A.3
Calin, G.A.4
Croce, C.5
-
19
-
-
3042767202
-
MicroRNAs: small RNAs with a big role in gene regulation
-
He L., Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 2004, 5:522-531.
-
(2004)
Nat. Rev. Genet.
, vol.5
, pp. 522-531
-
-
He, L.1
Hannon, G.J.2
-
20
-
-
0347444723
-
MicroRNAs: genomics, biogenesis, mechanism, and function
-
Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
-
(2004)
Cell
, vol.116
, pp. 281-297
-
-
Bartel, D.P.1
-
21
-
-
84880560749
-
Epigenetic silencing of monoallelically methylated miRNA loci in precancerous colorectal lesions
-
Menigatti M., Staiano T., Manser C.N., Bauerfeind P., Komljenovic A., Robinson M., Jiricny J., Buffoli F., Marra G. Epigenetic silencing of monoallelically methylated miRNA loci in precancerous colorectal lesions. Oncogenesis 2013, 2:e56.
-
(2013)
Oncogenesis
, vol.2
, pp. e56
-
-
Menigatti, M.1
Staiano, T.2
Manser, C.N.3
Bauerfeind, P.4
Komljenovic, A.5
Robinson, M.6
Jiricny, J.7
Buffoli, F.8
Marra, G.9
-
22
-
-
38349191617
-
CpG island hypermethylation of tumor suppressor microRNAs in human cancer
-
Lujambio A., Esteller M. CpG island hypermethylation of tumor suppressor microRNAs in human cancer. Cell Cycle 2007, 6:1455-1459.
-
(2007)
Cell Cycle
, vol.6
, pp. 1455-1459
-
-
Lujambio, A.1
Esteller, M.2
-
23
-
-
25444520537
-
MiR-15 and miR-16 induce apoptosis by targeting BCL2
-
Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., Wojcik S.E., Aqeilan R.I., Zupo S., Dono M., Rassenti L., Alder H., Volinia S., Liu C.G., Kipps T.J., Negrini M., Croce C.M. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:13944-13949.
-
(2005)
Proc. Natl. Acad. Sci. U. S. A.
, vol.102
, pp. 13944-13949
-
-
Cimmino, A.1
Calin, G.A.2
Fabbri, M.3
Iorio, M.V.4
Ferracin, M.5
Shimizu, M.6
Wojcik, S.E.7
Aqeilan, R.I.8
Zupo, S.9
Dono, M.10
Rassenti, L.11
Alder, H.12
Volinia, S.13
Liu, C.G.14
Kipps, T.J.15
Negrini, M.16
Croce, C.M.17
-
24
-
-
84879690994
-
MicroRNA-7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cells
-
Liu S., Zhang P., Chen Z., Liu M., Li X., Tang H. MicroRNA-7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cells. FEBS Lett. 2013, 587:2247-2253.
-
(2013)
FEBS Lett.
, vol.587
, pp. 2247-2253
-
-
Liu, S.1
Zhang, P.2
Chen, Z.3
Liu, M.4
Li, X.5
Tang, H.6
-
25
-
-
0034658551
-
The role of STATs in myeloid differentiation and leukemia
-
Coffer P.J., Koenderman L., de Groot R.P. The role of STATs in myeloid differentiation and leukemia. Oncogene 2000, 19:2511-2522.
-
(2000)
Oncogene
, vol.19
, pp. 2511-2522
-
-
Coffer, P.J.1
Koenderman, L.2
de Groot, R.P.3
-
26
-
-
0029063970
-
Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells
-
Skorski T., Kanakaraj P., Nieborowska-Skorska M., Ratajczak M.Z., Wen S.C., Zon G., Gewirtz A.M., Perussia B., Calabretta B. Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells. Blood 1995, 86:726-736.
-
(1995)
Blood
, vol.86
, pp. 726-736
-
-
Skorski, T.1
Kanakaraj, P.2
Nieborowska-Skorska, M.3
Ratajczak, M.Z.4
Wen, S.C.5
Zon, G.6
Gewirtz, A.M.7
Perussia, B.8
Calabretta, B.9
-
27
-
-
84871270903
-
Growth inhibitory effect of dihydroartemisinin on Bcr/Abl+ chronic myeloid leukemia K562 cells involve AKT, ERK and NF-κB modulation
-
Lee J., Zhang G., Wu X., Xu F., Zhou J., Zhang X. Growth inhibitory effect of dihydroartemisinin on Bcr/Abl+ chronic myeloid leukemia K562 cells involve AKT, ERK and NF-κB modulation. J. Cancer Res. Clin. Oncol. 2012, 138:2095-2102.
-
(2012)
J. Cancer Res. Clin. Oncol.
, vol.138
, pp. 2095-2102
-
-
Lee, J.1
Zhang, G.2
Wu, X.3
Xu, F.4
Zhou, J.5
Zhang, X.6
-
28
-
-
0032034216
-
A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation
-
Reuther J.Y., Reuther G.W., Cortez D., Pendergast A.M., Baldwin A.S. A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation. Genes Dev. 1998, 12:968-981.
-
(1998)
Genes Dev.
, vol.12
, pp. 968-981
-
-
Reuther, J.Y.1
Reuther, G.W.2
Cortez, D.3
Pendergast, A.M.4
Baldwin, A.S.5
-
29
-
-
0030710188
-
Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway
-
Skorski T., Bellacosa A., Nieborowska-Skorska M., Majewski M., Martinez R., Choi J.K., Trotta R., Wlodarski P., Perrotti D., Chan T.O., Wasik M.A., Tsichlis P.N., Calabretta B. Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway. EMBO J. 1997, 16:6151-6161.
-
(1997)
EMBO J.
, vol.16
, pp. 6151-6161
-
-
Skorski, T.1
Bellacosa, A.2
Nieborowska-Skorska, M.3
Majewski, M.4
Martinez, R.5
Choi, J.K.6
Trotta, R.7
Wlodarski, P.8
Perrotti, D.9
Chan, T.O.10
Wasik, M.A.11
Tsichlis, P.N.12
Calabretta, B.13
-
30
-
-
41149149301
-
Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B
-
Hennighausen L., Robinson G.W. Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B. Genes Dev. 2008, 22:711-721.
-
(2008)
Genes Dev.
, vol.22
, pp. 711-721
-
-
Hennighausen, L.1
Robinson, G.W.2
-
31
-
-
0029069145
-
Transcriptional responses to polypeptide ligands: the JAK-STAT pathway
-
Schindler C., Darnell J.E. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 1995, 64:621-651.
-
(1995)
Annu. Rev. Biochem.
, vol.64
, pp. 621-651
-
-
Schindler, C.1
Darnell, J.E.2
-
32
-
-
79953134246
-
Genomic views of STAT function in CD4+ T helper cell differentiation
-
O'Shea J.J., Lahesmaa R., Vahedi G., Laurence A., Kanno Y. Genomic views of STAT function in CD4+ T helper cell differentiation. Nat. Rev. Immunol. 2011, 11:239-250.
-
(2011)
Nat. Rev. Immunol.
, vol.11
, pp. 239-250
-
-
O'Shea, J.J.1
Lahesmaa, R.2
Vahedi, G.3
Laurence, A.4
Kanno, Y.5
-
33
-
-
0027405369
-
Phenotypic and molecular analysis of Ph1-chromosome-positive acute lymphoblastic leukemia cell lines
-
Miyagi T., Ohyashiki J., Yamato K., Koeffler H.P., Miyoshi I. Phenotypic and molecular analysis of Ph1-chromosome-positive acute lymphoblastic leukemia cell lines. Int. J. Cancer 1993, 53:457-462.
-
(1993)
Int. J. Cancer
, vol.53
, pp. 457-462
-
-
Miyagi, T.1
Ohyashiki, J.2
Yamato, K.3
Koeffler, H.P.4
Miyoshi, I.5
-
34
-
-
0020974381
-
Establishment of a Ph1 chromosome-positive cell line from chronic myelogenous leukemia in blast crisis
-
Kubonishi I., Miyoshi I. Establishment of a Ph1 chromosome-positive cell line from chronic myelogenous leukemia in blast crisis. Int. J. Cell Cloning 1983, 1:105-117.
-
(1983)
Int. J. Cell Cloning
, vol.1
, pp. 105-117
-
-
Kubonishi, I.1
Miyoshi, I.2
-
35
-
-
84895543685
-
Downregulation of miR-217 correlates with resistance of ph(+) leukemia cells to ABL tyrosine kinase inhibitors
-
Nishioka C., Ikezoe T., Yang J., Nobumoto A., Tsuda M., Yokoyama A. Downregulation of miR-217 correlates with resistance of ph(+) leukemia cells to ABL tyrosine kinase inhibitors. Cancer Sci. 2014, 105:297-307.
-
(2014)
Cancer Sci.
, vol.105
, pp. 297-307
-
-
Nishioka, C.1
Ikezoe, T.2
Yang, J.3
Nobumoto, A.4
Tsuda, M.5
Yokoyama, A.6
-
36
-
-
0037423845
-
Vertebrate microRNA genes
-
Lim L.P., Glasner M.E., Yekta S., Burge C.B., Bartel D.P. Vertebrate microRNA genes. Science 2003, 299:1540.
-
(2003)
Science
, vol.299
, pp. 1540
-
-
Lim, L.P.1
Glasner, M.E.2
Yekta, S.3
Burge, C.B.4
Bartel, D.P.5
-
37
-
-
84929645859
-
MicroRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer
-
Chen D.L., Zhang D.S., Lu Y.X., Chen L.Z., Zeng Z.L., He M.M., Wang F.H., Li Y.H., Zhang H.Z., Pelicano H., Zhang W., Xu R.H. microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer. Oncotarget 2015, 6:10868-10879.
-
(2015)
Oncotarget
, vol.6
, pp. 10868-10879
-
-
Chen, D.L.1
Zhang, D.S.2
Lu, Y.X.3
Chen, L.Z.4
Zeng, Z.L.5
He, M.M.6
Wang, F.H.7
Li, Y.H.8
Zhang, H.Z.9
Pelicano, H.10
Zhang, W.11
Xu, R.H.12
-
38
-
-
84871994982
-
STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2
-
Tam W.F., Hähnel P.S., Schüler A., Lee B.H., Okabe R., Zhu N., Pante S.V., Raffel G., Mercher T., Wernig G., Bockamp E., Sasca D., Kreft A., Robinson G.W., Hennighausen L., Gilliland D.G., Kindler T. STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2. Cancer Res. 2013, 73:373-384.
-
(2013)
Cancer Res.
, vol.73
, pp. 373-384
-
-
Tam, W.F.1
Hähnel, P.S.2
Schüler, A.3
Lee, B.H.4
Okabe, R.5
Zhu, N.6
Pante, S.V.7
Raffel, G.8
Mercher, T.9
Wernig, G.10
Bockamp, E.11
Sasca, D.12
Kreft, A.13
Robinson, G.W.14
Hennighausen, L.15
Gilliland, D.G.16
Kindler, T.17
-
39
-
-
35548954735
-
STAT5A is required for long-term maintenance of normal and leukemic human tem/progenitor cells
-
Schepers H., van Gosliga D., Wierenga A.T., Eggen B.J., Schuringa J.J., Vellenga E. STAT5A is required for long-term maintenance of normal and leukemic human tem/progenitor cells. Blood 2007, 110:2880-2888.
-
(2007)
Blood
, vol.110
, pp. 2880-2888
-
-
Schepers, H.1
van Gosliga, D.2
Wierenga, A.T.3
Eggen, B.J.4
Schuringa, J.J.5
Vellenga, E.6
-
40
-
-
33947267129
-
Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells
-
Moore M.A., Dorn D.C., Schuringa J.J., Chung K.Y., Morrone G. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells. Exp. Hematol. 2007, 35:105-116.
-
(2007)
Exp. Hematol.
, vol.35
, pp. 105-116
-
-
Moore, M.A.1
Dorn, D.C.2
Schuringa, J.J.3
Chung, K.Y.4
Morrone, G.5
-
41
-
-
84864567410
-
Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia
-
Tanaka S., Miyagi S., Sashida G., Chiba T., Yuan J., Mochizuki-Kashio M., Suzuki Y., Sugano S., Nakaseko C., Yokote K., Koseki H., Iwama A. Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia. Blood 2012, 120:1107-1117.
-
(2012)
Blood
, vol.120
, pp. 1107-1117
-
-
Tanaka, S.1
Miyagi, S.2
Sashida, G.3
Chiba, T.4
Yuan, J.5
Mochizuki-Kashio, M.6
Suzuki, Y.7
Sugano, S.8
Nakaseko, C.9
Yokote, K.10
Koseki, H.11
Iwama, A.12
-
42
-
-
77953289499
-
Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells
-
Hua W.F., Fu Y.S., Liao Y.J., Xia W.J., Chen Y.C., Zeng Y.X., Kung H.F., Xie D. Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells. Eur. J. Pharmacol. 2010, 637:16-21.
-
(2010)
Eur. J. Pharmacol.
, vol.637
, pp. 16-21
-
-
Hua, W.F.1
Fu, Y.S.2
Liao, Y.J.3
Xia, W.J.4
Chen, Y.C.5
Zeng, Y.X.6
Kung, H.F.7
Xie, D.8
-
43
-
-
84868087652
-
Downregulation of Ezh2 expression by RNA interference induces cell cycle arrest in the G0/G1 phase and apoptosis in U87 human glioma cells
-
Zhang R., Wang R., Chang H., Wu F., Liu C., Deng D., Fan W. Downregulation of Ezh2 expression by RNA interference induces cell cycle arrest in the G0/G1 phase and apoptosis in U87 human glioma cells. Oncol. Rep. 2012, 28:2278-2284.
-
(2012)
Oncol. Rep.
, vol.28
, pp. 2278-2284
-
-
Zhang, R.1
Wang, R.2
Chang, H.3
Wu, F.4
Liu, C.5
Deng, D.6
Fan, W.7
-
44
-
-
33745175876
-
Activation of the NF-kappaB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKalpha
-
Malinge S., Monni R., Bernard O., Penard-Lacronique V. Activation of the NF-kappaB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKalpha. Oncogene 2006, 25:3589-3597.
-
(2006)
Oncogene
, vol.25
, pp. 3589-3597
-
-
Malinge, S.1
Monni, R.2
Bernard, O.3
Penard-Lacronique, V.4
-
45
-
-
77956930205
-
Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin
-
Momeny M., Zakidizaji M., Ghasemi R., Dehpour A.R., Rahimi-Balaei M., Abdolazimi Y., Ghavamzadeh A., Alimoghaddam K., Ghaffari S.H. Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin. Med. Oncol. 2010, 27:833-842.
-
(2010)
Med. Oncol.
, vol.27
, pp. 833-842
-
-
Momeny, M.1
Zakidizaji, M.2
Ghasemi, R.3
Dehpour, A.R.4
Rahimi-Balaei, M.5
Abdolazimi, Y.6
Ghavamzadeh, A.7
Alimoghaddam, K.8
Ghaffari, S.H.9
-
46
-
-
33645640920
-
The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases
-
Eckelman B.P., Salvesen G.S. The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases. J. Biol. Chem. 2006, 281:3254-3260.
-
(2006)
J. Biol. Chem.
, vol.281
, pp. 3254-3260
-
-
Eckelman, B.P.1
Salvesen, G.S.2
-
47
-
-
33645103808
-
Chemosensitization effects of XIAP downregulation in K562 leukemia cells
-
Lima R.T., Martins L.M., Guimarães J.E., Sambade C., Vasconcelos M.H. Chemosensitization effects of XIAP downregulation in K562 leukemia cells. J. Chemother. 2006, 18:98-102.
-
(2006)
J. Chemother.
, vol.18
, pp. 98-102
-
-
Lima, R.T.1
Martins, L.M.2
Guimarães, J.E.3
Sambade, C.4
Vasconcelos, M.H.5
-
48
-
-
84890628296
-
Berberine induces apoptosis in p53-null leukemia cells by down-regulating XIAP at the post-transcriptional level
-
Liu J., Zhang X., Liu A., Liu S., Zhang L., Wu B., Hu Q. Berberine induces apoptosis in p53-null leukemia cells by down-regulating XIAP at the post-transcriptional level. Cell. Physiol. Biochem. 2013, 32:1213-1224.
-
(2013)
Cell. Physiol. Biochem.
, vol.32
, pp. 1213-1224
-
-
Liu, J.1
Zhang, X.2
Liu, A.3
Liu, S.4
Zhang, L.5
Wu, B.6
Hu, Q.7
|